WO2019116329A8 - Use of maltodextrin for enhancing or improving cognition and/or stimulating brain development - Google Patents

Use of maltodextrin for enhancing or improving cognition and/or stimulating brain development Download PDF

Info

Publication number
WO2019116329A8
WO2019116329A8 PCT/IB2018/060083 IB2018060083W WO2019116329A8 WO 2019116329 A8 WO2019116329 A8 WO 2019116329A8 IB 2018060083 W IB2018060083 W IB 2018060083W WO 2019116329 A8 WO2019116329 A8 WO 2019116329A8
Authority
WO
WIPO (PCT)
Prior art keywords
maltodextrin
enhancing
brain development
stimulating brain
improving cognition
Prior art date
Application number
PCT/IB2018/060083
Other languages
French (fr)
Other versions
WO2019116329A1 (en
Inventor
Cindy LE BOURGOT
Frédérique RESPONDEK
Caroline CLOUARD
Walter GERRITS
Original Assignee
Tereos Starch & Sweeteners Belgium
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tereos Starch & Sweeteners Belgium filed Critical Tereos Starch & Sweeteners Belgium
Publication of WO2019116329A1 publication Critical patent/WO2019116329A1/en
Publication of WO2019116329A8 publication Critical patent/WO2019116329A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Pediatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention concerns the use of a maltodextrin or a composition comprising thereof as the main source of carbohydrates in infant nutrition during the early childhood of a mammal for improving or enhancing cognitive performance and/or stimulating brain development.
PCT/IB2018/060083 2017-12-14 2018-12-14 Use of maltodextrin for enhancing or improving cognition and/or stimulating brain development WO2019116329A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR17/01309 2017-12-14
FR1701309A FR3075001B1 (en) 2017-12-14 2017-12-14 USE OF MALTODEXTRINS TO IMPROVE COGNITION AND / OR STIMULATE BRAIN DEVELOPMENT

Publications (2)

Publication Number Publication Date
WO2019116329A1 WO2019116329A1 (en) 2019-06-20
WO2019116329A8 true WO2019116329A8 (en) 2020-01-30

Family

ID=61801996

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2018/060083 WO2019116329A1 (en) 2017-12-14 2018-12-14 Use of maltodextrin for enhancing or improving cognition and/or stimulating brain development

Country Status (2)

Country Link
FR (1) FR3075001B1 (en)
WO (1) WO2019116329A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2327733A1 (en) * 1975-10-16 1977-05-13 Lyall Neil Powdered whole milk substitute - contg. whey or malto-dextrin as filler, hardened plant oil, sweetener and emulsifier
ATE445406T1 (en) * 2005-02-09 2009-10-15 Vifor Int Ag USE OF IRON(III) COMPLEX COMPOUNDS
FR2884422B1 (en) * 2005-04-18 2008-04-11 Roquette Freres ANTI-INFLAMMATORY COMPOSITION OF INTESTINES COMPRISING BRANCHED MALTODEXTRINS
EP2422629A1 (en) * 2010-08-23 2012-02-29 Abbott Laboratories Methods for enhancing cognition and/or memory using maltodextrins
CN106615178B (en) * 2017-01-13 2020-08-04 汉臣氏（沈阳）儿童制品有限公司 DHA algae oil solid beverage

Also Published As

Publication number Publication date
WO2019116329A1 (en) 2019-06-20
FR3075001B1 (en) 2021-09-10
FR3075001A1 (en) 2019-06-21

Similar Documents

Publication Publication Date Title
PH12020551397A1 (en) Cot modulators and methods of use thereof
GEP20217326B (en) Constructs having a sirp-alpha domain or variant thereof
NZ731467A (en) Anti-tim3 antibodies and methods of use
BR112017011215A2 (en) pro-flavoring distribution particles
PH12016501618A1 (en) Anti-dll3 antibodies and drug conjugates for use in melanoma
MY193727A (en) Immune modulation and treatment of solid tumors with antibodies that specifically bind cd38
MY193723A (en) Combination therapy of tumor-targeted il-2 variant immunocytokines and antibodies against human pd-l1
EP3325473A4 (en) Compounds and uses thereof in the treatment of cancers and other medical conditions
EA201790405A1 (en) COMPOSITIONS AND METHODS OF TREATMENT OF METABOLIC DISORDERS
MX2018010295A (en) Antibodies having specificity for btla and uses thereof.
TW201613962A (en) Fabs-in-tandem immunoglobulin and uses thereof
MX2016003129A (en) Combination therapy of antibodies against human csf-1r and antibodies against human pd-l1.
MX2019013670A (en) Antibody and protein formulations.
GEP20217317B (en) Combination therapy for the treatment of cancer
MX2017017124A (en) 6-amino-quinoline-3-carbonitrils as cot modulators.
MX2018002546A (en) Compositions comprising an urolithin compound.
MX2020003219A (en) Antibodies having specificity for btn2 and uses thereof.
MX2019005299A (en) Fcrn-binding abolished anti-igf-1r antibodies and their use in the treatment of vascular eye diseases.
MX2017006019A (en) Apilimod for use in the treatment of melanoma.
MX2015010023A (en) Anti-cd83 antibodies and use thereof.
PH12016501434A1 (en) Compositions for use in the treatment of allergic conditions
MX2016015280A (en) Anti-brdu antibodies and methods of use.
MX2020002585A (en) Hdac inhibitor in combination with immune checkpoint modulator for cancer therapy.
WO2019116329A8 (en) Use of maltodextrin for enhancing or improving cognition and/or stimulating brain development
MX2017003949A (en) Novel peptide derivatives and uses thereof.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18836521

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18836521

Country of ref document: EP

Kind code of ref document: A1